Arterial hypertension therapy effectiveness in smokers

by D. V. Nebieridze, F. A. Papova, N. S. Ivanishina, A. S. Safaryan, N. L. Vinnitskaya, A. Meliya
Published 2007-02-01

Angioprotection role in arterial hypertension treatment: focus on olmesartan

by D. V. Nebieridze, A. S. Safaryan, T. V. Ivanishina, N. L. Vinnitskaya
Published 2012-10-01

COMMENTS ON NEW EUROPEAN GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION

by D. V. Nebieridze
Published 2016-01-01

Rosuvastatin microcirculatory effects in patients with dyslipidemia and arterial hypertension

by D. V. Nebieridze, G. R. Kulieva, V. A. Vygodin
Published 2006-08-01

SYSTOLIC ARTERIAL HYPERTENSION: THE PLACE OF ANGIOTENSIN II RECEPTOR BLOCKERS

by D. V. Nebieridze
Published 2002-02-01

The role of plant stanols in the primary prevention of hypercholesterolemia in patients with arterial hypertension

by A. S. Safaryan, T. V. Kamyshova, D. V. Nebieridze, V. D. Sargsyan
Published 2019-06-01

A STUDY OF MOXONIDINE’S METABOLIC EFFECTS IN PATIENTS WITH ARTERIAL HYPERTENSION AND NIDDM

by D. V. Nebieridze, A. N. Britov, O. V. Shekina, N. V. Perova, N. L. Vinnitskaya, R. G. Oganov
Published 2001-04-01

Patients’ education as a factor for arterial hypertension effective control – NOCTURNE Program

by A. M. Kalinina, R. G. Oganov, D. V. Nebieridze
Published 2006-06-01

Effectiveness of ACE inhibitor ramipril and its combination with hydrochlorothiazide in patients with arterial hypertension and overweight: CHARISMA Study

by I. P. Kolos, T. V. Martynyuk, A. S. Safaryan, D. V. Nebieridze, I. E. Chazova
Published 2008-04-01

BETA-ADRENOBLOCKER THERAPY IN ARTERIAL HYPERTENSION, METABOLIC DISTURBANCES, AND TYPE 2 DIABETES MELLITUS

by D. V. Nebieridze, R. G. Kulieva, V. D. Sargsyan, N. L. Vinnitskaya
Published 2009-08-01

ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES

by S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin
Published 2015-12-01

ARTERIAL HYPERTENSION IN RUSSIA: PROLOG STUDY AS A PROOF METHOD OF CONTEMPORARY THERAPY OPPORTUNITIES

by S. A. Shalnova, S. Y. Martsevich, A. D. Deev, N. P. Kutishenko, P. G. Oganov, A. N. Britov, E. G. Volkova, K. I. Ivanov, A. M. Kalinina, L. I. Katelnitskaya, G. D. Kobalava, E. V. Kokurina, A. O. Conradi, S. K. Kukushkin, Yu. M. Lopatin, N. I. Maksimov, V. Y. Mareev, I. S. Petelin, D. V. Nebieridze, G. I. Nechayev, L. A. Sokolova, A. V. Suslikov, I. G. Fomina, A. V. Shabalin, V. A. Shulman, V. V. Yakusevich, S. S. Jakushin
Published 2015-12-01

Cardiovascular risk profile in patients with arterial hypertension who first seek medical attention

by D. V. Nebieridze, T. V. Kamyshova, A. A. Sarycheva, A. S. Safaryan
Published 2018-10-01

ARTERIAL HYPERTENSION WORKGROUP RESOLUTION. THE ROLE OF SARTANS IN TREATMENT OF SYSTEMIC HYPERTENSION IN THE 21ST CENTURY

by A. O. Konradi, O. N. Zhdanova, O. P. Rotar, Yu. A. Karpov, V. I. Podzolkov, P. A. Lebedev, A. I. Chesnikova, D. V. Nebieridze, O. N. Miller, E. V. Solovjova, A. N. Kulikov
Published 2018-04-01

METABOLIC EFFECTS OF ALTIAZEM-PP, A PROLONGED CALCIUM ANTAGONIST, IN PATIENTS WITH MILD ARTERIAL HYPERTENSION

by I. A. Tvaladze, D. V. Nebieridze, A. N. Britov, V. I. Buvalcev, V. M. Gorbunov, Y. B. Yarovaya
Published 2001-08-01

Guidelines on treatment of patients with arterial hypertension comorbid with metabolic disorders and diabetes mellitus type 2

by I. E. Chazova, M. V. Shestakova, Yu. V. Zhernakova, T. N. Markova, N. V. Mazurina, M. V. Yezhov, O. Yu. Mironova, A. Yu. Litvin, E. M. Elfimova, N. V. Blinova, O. Yu. Sukhareva, A. S. Ametov, N. M. Akhmedzhanov, O. A. Kislyak, V. V. Kukharchuk, S. V. Nedogoda, D. V. Nebieridze, I. V. Medvedev, A. M. Mkrtumyan, V. I. Podzolkov
Published 2020-05-01

Results of the multi-centre study NOCTURN-2 in patients with arterial hypertension, uncontrolled by previous pharmaceutical therapy

by R. G. Oganov, D. V. Nebieridze, S. A. Shalnova, A. M. Kalinina, A. S. Safaryan, A. D. Deev
Published 2010-02-01

IMIDAZOLINE RECEPTOR AGONISTS: DO WE KNOW EVERYTHING ABOUT THEIR CAPABILITIES?

by D. V. Nebieridze, T. V. Kamyshova
Published 2015-12-01

Assessment of pleiotropic effects of nebivolol: influence on microcirculation parameters and bone tissue in postmenopausal women with mild arterial hypertension

by I. L. Tepojan, D. V. Nebieridze, I. A. Skripnikova, A. S. Safarjan, V. E. Novikov, L. M. Murashko, V. A. Vygodin
Published 2016-04-01

HYPOLIPIDEMIC AND PLEIOTROPIC EFFICACY OF ROSUVASTATIN IN ARTERIAL HYPERTENSION PATIENTS OF HIGH CARDIOVASCULAR RISK IN LONG-TERM OUTPATIENT FOLLOW-UP

by V. P. Mikhin, Yu. A. Zhilyaeva, V. V. Vorotyntseva, D. V. Nebieridze, N. M. Akhmedzhanov, D. A. Vasil’eva, M. A. Chernyatina, N. A. Gromnatsky
Published 2016-12-01